beta-naphthamidine has been researched along with b 428 in 1 studies
| Studies (beta-naphthamidine) | Trials (beta-naphthamidine) | Recent Studies (post-2010) (beta-naphthamidine) | Studies (b 428) | Trials (b 428) | Recent Studies (post-2010) (b 428) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 17 | 1 | 3 |
| Protein | Taxonomy | beta-naphthamidine (IC50) | b 428 (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 0.32 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, C; Dorwin, S; Giranda, VL; Hulkower, KI; Klinghofer, V; McGonigal, T; Nienaber, V; Richardson, P; Rockway, T; Sarthy, A; Smith, R; Stewart, K; Weitzberg, M; Wendt, M; Zhao, X | 1 |
1 other study(ies) available for beta-naphthamidine and b 428
| Article | Year |
|---|---|
Species specificity of amidine-based urokinase inhibitors.
Topics: Amidines; Amiloride; Amino Acid Sequence; Animals; Antineoplastic Agents; Binding Sites; Blood Proteins; Carcinoma, Lewis Lung; Crystallography, X-Ray; Humans; Mice; Molecular Sequence Data; Naphthalenes; Sequence Alignment; Sequence Homology, Amino Acid; Serine Proteinase Inhibitors; Species Specificity; Thiophenes; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2001 |